EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

From CAR-T Cells to Exosome-Based Immunotherapy: Exploring the Frontiers of Cell-Free Targeted Cancer Therapeutics

Alexandru Tîrziu, Florina Maria Bojin iD, Oana Isabella Gavriliuc iD, Cosmin Ioan Faur iD, Virgil Păunescu

Cells · 2025

DOI: 10.3390/cells15010070 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, 2025. Verfasst von Alexandru Tîrziu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Functional Sciences, "Victor Babes" University of Medicine and Pharmacy, Tudor Vladimirescu Street, No. 14, 300174 Timisoara, Romania. Hauptthemen laut MEDLINE: Exosomes, Neoplasms, Immunotherapy, Receptors, Chimeric Antigen. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 288 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Planul Național de Redresare și Reziliență a României, RBC-engager for NK and T cell activation in cancer immunotherapy, “Victor Babes” University of Medicine and Pharmacy Timisoara.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chimeric antigen receptor (CAR) cell therapies have revolutionized cancer immunotherapy by enabling targeted and potent antitumor immune responses. However, clinical challenges such as limited efficacy in solid tumors, severe toxicities including cytokine release syndrome (CRS), and manufacturing complexities restrict their broader use. Recently, CAR cell-derived exosomes (CAR-Exos) have emerged as promising cell-free therapeutic alternatives that retain the key antitumor functionalities of their parent cells while potentially overcoming the limitations of live cellular therapies. These nanoscale vesicles can deliver bioactive CAR molecules, cytotoxic proteins, and immunomodulatory cargo, enabling targeted tumor cell killing with reduced systemic toxicity and offering “off-the-shelf” applicability. This review comprehensively explores the biology, engineering, and therapeutic potential of CAR-Exos derived from T cells, natural killer (NK) cells, and other immune effectors. We discuss advances in isolation, characterization, and cargo profiling techniques, as well as preclinical and early clinical data supporting their application. Further, we address translational challenges including large-scale production, biodistribution, and immune evasion in tumor microenvironments. Combining cellular and exosomal CAR platforms holds promise to enhance efficacy and safety in cancer treatment, representing a frontier in targeted immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ExosomesNeoplasmsImmunotherapyReceptors, Chimeric AntigenT-LymphocytesImmunotherapy, AdoptiveHumansAnimalsTumor Microenvironment

Stichwörter der Autor:innen

CAR-NK cellsCAR-T cell therapycancer immunotherapycell-free therapeuticsexosome-based immunotherapyextracellular vesiclestumor microenvironment

Substanzen

Receptors, Chimeric Antigen

Autor:innen und Institutionen

  • Department of Functional Sciences, "Victor Babes" University of Medicine and Pharmacy, Tudor Vladimirescu Street, No. 14, 300174 Timisoara, Romania.
  • Center for Gene and Cellular Therapies in the Treatment of Cancer Timisoara-OncoGen, Clinical Emergency County Hospital "Pius Brinzeu" Timisoara, No. 156 Liviu Rebreanu, 300723 Timisoara, Romania.
  • Immuno-Physiology and Biotechnologies Center, Department of Functional Sciences, "Victor Babes" University of Medicine and Pharmacy, No. 2 Eftimie Murgu Square, 300041 Timisoara, Romania.
  • Department of Orthopedics-Traumatology, Urology, and Medical Imaging, "Victor Babes" University of Medicine and Pharmacy, Eftimie Murgu Square, No. 2, 300041 Timisoara, Romania.

ORCID-Profile: Florina Maria Bojin, Oana Isabella Gavriliuc, Cosmin Ioan Faur

Förderung

  • Planul Național de Redresare și Reziliență a României
  • RBC-engager for NK and T cell activation in cancer immunotherapy
  • “Victor Babes” University of Medicine and Pharmacy Timisoara

Zitieren

APA

Tîrziu, A., Bojin, F. M., Gavriliuc, O. I., Faur, C. I., & Păunescu, V. (2025). From CAR-T Cells to Exosome-Based Immunotherapy: Exploring the Frontiers of Cell-Free Targeted Cancer Therapeutics. Cells. https://doi.org/10.3390/cells15010070

Vancouver

Tîrziu A, Bojin FM, Gavriliuc OI, Faur CI, Păunescu V. From CAR-T Cells to Exosome-Based Immunotherapy: Exploring the Frontiers of Cell-Free Targeted Cancer Therapeutics. Cells. 2025. doi:10.3390/cells15010070

BibTeX
@article{Trziu2025,
  author = {Tîrziu, Alexandru and Bojin, Florina Maria and Gavriliuc, Oana Isabella and Faur, Cosmin Ioan and Păunescu, Virgil},
  title = {From CAR-T Cells to Exosome-Based Immunotherapy: Exploring the Frontiers of Cell-Free Targeted Cancer Therapeutics},
  journal = {Cells},
  year = {2025},
  doi = {10.3390/cells15010070}
}
Kostenlos starten →